Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Avastin with Chemotherapy in Squamous NSCLC
NCT00404703Phase 2Terminated
- Sponsor
- Roche
- Start
- Aug 2006
- Primary completion
- Feb 2008
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 2 trial of bevacizumab in squamous cell carcinoma of the lung (SCCL), sponsored by Roche. Started Aug 2006; status: terminated.
02
Drugs
bevacizumab
03
Conditions
squamous cell carcinoma of the lung (SCCL)
Beyond the preview
Go deeper on NCT00404703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404703.